Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease
| dc.contributor.author | Clark, Ian A | |
| dc.contributor.author | Vissel, Bryce | |
| dc.date.accessioned | 2015-12-13T22:30:34Z | |
| dc.date.issued | 2013 | |
| dc.date.updated | 2016-02-24T09:24:40Z | |
| dc.description.abstract | The disappointments of a series of large anti-amyloid trials have brought home the point that until the driving force behind Alzheimer's disease, and the way it causes harm, are firmly established and accepted, researchers will remain ill-equipped to find | |
| dc.identifier.issn | 0006-2952 | |
| dc.identifier.uri | http://hdl.handle.net/1885/74904 | |
| dc.publisher | Elsevier | |
| dc.source | Biochemical Pharmacology | |
| dc.subject | Keywords: alpha synuclein; amyloid; apolipoprotein E2; apolipoprotein E3; apolipoprotein E4; bexarotene; calcineurin; cryopyrin; cytokine; DNA methyltransferase 1; insulin; interleukin 1; interleukin 12; interleukin 17; interleukin 23; membrane receptor; monoclonal Alzheimer's disease; DNA hypomethylation; Insulin resistance; Parkinson's disease, a-Synuclein; TNF | |
| dc.title | Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease | |
| dc.type | Journal article | |
| local.bibliographicCitation.issue | 7 | |
| local.bibliographicCitation.lastpage | 871 | |
| local.bibliographicCitation.startpage | 862 | |
| local.contributor.affiliation | Clark, Ian A, College of Medicine, Biology and Environment, ANU | |
| local.contributor.affiliation | Vissel, Bryce, Garvan Institute of Medical Research | |
| local.contributor.authoruid | Clark, Ian A, a261318 | |
| local.description.embargo | 2037-12-31 | |
| local.description.notes | Imported from ARIES | |
| local.identifier.absfor | 111500 - PHARMACOLOGY AND PHARMACEUTICAL SCIENCES | |
| local.identifier.ariespublication | f5625xPUB4367 | |
| local.identifier.citationvolume | 86 | |
| local.identifier.doi | 10.1016/j.bcp.2013.07.030 | |
| local.identifier.scopusID | 2-s2.0-84884704633 | |
| local.type.status | Published Version |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- 01_Clark_Treatment_implications_of_the_2013.pdf
- Size:
- 881.5 KB
- Format:
- Adobe Portable Document Format